Navigation Links
MaxWell Biocorporation, LLC, and International Medical Information Technologies, Inc., Announce Partnership
Date:8/1/2008

- Sponsorship Agreement Promotes International Medical Education, Helps

Break Down Language Barrier -

WASHINGTON, Aug. 1 /PRNewswire/ -- Russian-speaking medical professionals around the world have a potent new ally to help them integrate into the English-speaking mainstream of global medical research.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080624/NETU078LOGO )

Dr. Peter M. Leitner, President of MaxWell USA, LLC, and Dr. Marina Filshtinsky, President of Boston-based International Medical Information Technologies, Inc. (IMIT) and editor-in-chief of MedMir.com, announced today a sponsorship deal between their two organizations.

MaxWell USA will provide the first significant outside funding received by IMIT since its 2005 inception. As a result, IMIT will be in a stronger position to supply timely, comprehensive, and free translations of leading medical journal articles to Russian-speaking medical professionals around the world.

By partnering, MaxWell and IMIT will contribute more effectively to improving the quality of healthcare offered by Russian-speaking medical providers to their patients wherever they may be.

About MedMir

MedMir.com (http://www.medmir.com) is the first project of the Boston-based nonprofit organization International Medical Information Technologies, Inc., IMIT (http://www.imithome.org). MedMir provides Russian-speaking medical professionals around the world with free access to timely, comprehensive, and accurate summaries of leading research papers from the world's top medical journals, translated by highly qualified medical specialists. The MedMir project began in January 2005 and has consistently attracted a growing number of Russian-speaking medical professional visitors to its website. MedMir is the only service on the Internet that provides timely, comprehensive international medical information in Russian. MedMir.com = World Medical Journal Reviews In Russian.

About MaxWell

MaxWell Biocorporation (http://www.max-well.com) is a U.S.-based, privately-held international medical and pharmaceutical company with wholly owned subsidiaries and affiliates in the United States and Ukraine dedicated to increasing life expectancy and improving the quality of life of people in Ukraine and other underserved emerging healthcare markets in the former Soviet Union. MaxWell targets oncological, cardiological, chronic infectious and autoimmune disorders and diseases through the development, production, and introduction into clinical practice of sophisticated, high quality, and affordable off-patent generic biopharmaceutical and chemopharmaceutical medicines and the latest diagnostic and therapeutic methods. MaxWell = "Maximum Wellness."

"We Help You Live Longer"

Contact:

Alex Meerovich

A.Meerovich@max-well.com

202-454-3403 Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Kenneth Alibek https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78826 Peter Leitner https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78827


'/>"/>
SOURCE MaxWell Biocorporation, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. U.S. Commerce Secretary Gutierrez Cuts Ribbon on MaxWell Biocorporations New Pharmaceutical Development Center and Quality Control Laboratory in Ukraine
2. PURE Bioscience Announces DuraBan International as Distributor of SDC-Based Disinfectant
3. Geecf: Spectrum Blue Steel Announces Strategic Partnership with Al Manhal International Group of Abu Dhabi to Deploy Biosphere Facilities
4. Pharmasmart International Taps Top Executive Ashton Maaraba to Head Global Sales and Marketing
5. BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc.
6. Ardea to Present Data on Lead HIV Candidate, RDEA806, at XVII International AIDS Conference
7. Cryo-Cell International, Inc. Reports Second Quarter 2008 Results
8. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
9. Access Pharmaceuticals Presents New Data at International Symposium Showing Companys Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells
10. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use
11. PAREXEL International Updates Earnings Guidance in Conjunction with Its Investor Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016 Eutilex Co. Ltd. today announced ... $18.9M) Series A financing. This financing round included participation ... and SNU Bio Angel. This new funding brings the ... (US $27.7M) since its founding in 2015. ... development and commercialization of its immuno-oncology programs, expand its ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... phase I/II dose escalation and expansion clinical trial for its lead drug candidate, ... The purpose of the trial was to determine the safety, antitumor activity, and ...
(Date:12/7/2016)... Dec. 7, 2016 Neogen Corporation (NASDAQ: ... Dan Kephart as its chief science officer ... assume his responsibilities at Neogen effective Jan. 1. ... for the agribusiness unit of Thermo Fisher Scientific, as ... Life Technologies. His extensive industry experience also includes the ...
(Date:12/7/2016)... OTTAWA, Ontario , Dec. 7, 2016 /PRNewswire/ ... partnership with General Atomics (GA), welcome today,s award ... National Nuclear Security Administration (NNSA) of the Phase ... its project with Nordion and the University of ... Phase II funding will support the establishment of ...
Breaking Biology Technology:
(Date:6/21/2016)... Columbia , June 21, 2016 ... to the new role of principal product architect ... named the director of customer development. Both will ... chief technical officer. The moves reflect NuData,s strategic ... in response to high customer demand and customer ...
(Date:6/16/2016)... SAN FRANCISCO , June 16, 2016 /PRNewswire/ ... Market size is expected to reach USD ... report by Grand View Research, Inc. Technological proliferation ... and banking applications are expected to drive the ... ) , The development of ...
(Date:6/9/2016)... control systems is proud to announce the introduction of fingerprint attendance control software, allowing ... are actually signing in, and to even control the opening of doors. ... ... ... Photo - http://photos.prnewswire.com/prnh/20160609/377487 ...
Breaking Biology News(10 mins):